BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10706857)

  • 1. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO).
    Bacigalupo A; Bruno B; Saracco P; Di Bona E; Locasciulli A; Locatelli F; Gabbas A; Dufour C; Arcese W; Testi G; Broccia G; Carotenuto M; Coser P; Barbui T; Leoni P; Ferster A
    Blood; 2000 Mar; 95(6):1931-4. PubMed ID: 10706857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor.
    Dinçol G; Aktan M; Diz-Küçükkaya R; Yavuz S; Nalçaci M; Oztürk S; Palanduz S; Doğan O; Ağan M
    Am J Hematol; 2007 Sep; 82(9):783-6. PubMed ID: 17506070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.
    Bacigalupo A; Broccia G; Corda G; Arcese W; Carotenuto M; Gallamini A; Locatelli F; Mori PG; Saracco P; Todeschini G
    Blood; 1995 Mar; 85(5):1348-53. PubMed ID: 7532040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Di Bona E; Rodeghiero F; Bruno B; Gabbas A; Foa P; Locasciulli A; Rosanelli C; Camba L; Saracco P; Lippi A; Iori AP; Porta F; De Rossi G; Comotti B; Iacopino P; Dufour C; Bacigalupo A
    Br J Haematol; 1999 Nov; 107(2):330-4. PubMed ID: 10583220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Schrezenmeier H; Socié G; Marsh J; Bacigalupo A; Dührsen U; Franzke A; Hallek M; Thiel E; Wilhelm M; Höchsmann B; Barrois A; Champion K; Passweg JR
    Blood; 2011 Apr; 117(17):4434-41. PubMed ID: 21233311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia.
    Kojima S; Hibi S; Kosaka Y; Yamamoto M; Tsuchida M; Mugishima H; Sugita K; Yabe H; Ohara A; Tsukimoto I
    Blood; 2000 Sep; 96(6):2049-54. PubMed ID: 10979946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early hemopoietic progenitors in the peripheral blood of patients with severe aplastic anemia (SAA) after treatment with antilymphocyte globulin (ALG), cyclosporin-A and G-CSF.
    Bacigalupo A; Piaggio G; Podestà M; Tong J; Pitto A; Figari O; Benvenuto F; Vassallo F; Tedone E; Grassia L; Van Lint MT; Gualandi F; Hoffman R
    Haematologica; 1997; 82(2):133-7. PubMed ID: 9175313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
    Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
    Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
    Rosenfeld S; Follmann D; Nunez O; Young NS
    JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of immunosuppressive therapy in children with severe aplastic anaemia. Report by the Polish Paediatric Leukaemia and Lymphoma Study Group].
    Pawelec K; Matysiak M; Niewiadomska E; Rokicka-Milewska R; Kowalczyk J; Stefaniak J; Balwierz W; Załecka-Czepko E; Chybicka A; Szmyd K; Sońta-Jakimczyk D; Bubała H; Krauze A; Wysocki M; Kurylak A; Wachowiak J; Kaczmarek-Kanold M; Stolarska M; Karolczyk I; Krawczuk-Rybak M; Leszczyńska E; Urasiński T; Peregud-Pogorzelski J; Balcerska A; Włazłowski M
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):832-9. PubMed ID: 17317914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of aplastic anemia with antithymocyte globulin, cyclosporin A, methylprednisolone, danazol and recombinant human granulocyte-colony stimulating factor.
    Shichino H; Mugishima H; Takamura M; Shimada T; Suzuki T; Chin M; Harada K; Ryo S; Kojima S
    Acta Paediatr Jpn; 1996 Dec; 38(6):644-7. PubMed ID: 9002302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis.
    Wei J; Huang Z; Guo J; Zhang Y; Wang C; Zhu X; Zhang Y
    Ann Hematol; 2015 Jun; 94(6):955-62. PubMed ID: 25666078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified immunosuppressive therapy with porcine antilymphocyte globulin plus delayed cyclosporine A in children with severe aplastic anemia.
    Cui Q; Sha P; Chen H; Shen H; Qin L; Li Z; Wu T; Wang Z
    Int J Hematol; 2018 Jan; 107(1):64-68. PubMed ID: 28900860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation.
    Tichelli A; de Latour RP; Passweg J; Knol-Bout C; Socié G; Marsh J; Schrezenmeier H; Höchsmann B; Bacigalupo A; Samarasinghe S; Rovó A; Kulasekararaj A; Röth A; Eikema DJ; Bosman P; Bader P; Risitano A; Dufour C;
    Haematologica; 2020 May; 105(5):1223-1231. PubMed ID: 31582549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.
    Frickhofen N; Kaltwasser JP; Schrezenmeier H; Raghavachar A; Vogt HG; Herrmann F; Freund M; Meusers P; Salama A; Heimpel H
    N Engl J Med; 1991 May; 324(19):1297-304. PubMed ID: 2017225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
    Frickhofen N; Heimpel H; Kaltwasser JP; Schrezenmeier H;
    Blood; 2003 Feb; 101(4):1236-42. PubMed ID: 12393680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment.
    Meidlinger P; Knöbl P; Jäger U; Gisslinger H; Pabinger I; Weltermann A; Lechner K; Geissler K
    Ann Hematol; 1999 Jul; 78(7):299-304. PubMed ID: 10466441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.